Laparoscopic gastric devascularization and splenectomy for sclerotherapy-resistant esophagogastric varices with hypersplenism.

BACKGROUND The combination of sclerotherapy with surgical salvage for sclerotherapy-resistant esophagogastric varices has recently received much attention, however, the longterm results after such an operation have yet to be reported. This is a preliminary report of a laparoscopic adaptation of a previously described surgical procedure for the treatment of refractory esophagogastric varices. STUDY DESIGN Laparoscopic gastric devascularization and splenectomy (Hassab's operation) was successfully performed to treat recurrent sclerotherapy-resistant giant esophageal varices (n=4) and recurrent rebleeding gastric varices (n=6). The patients included 8 men and 2 women who ranged in age from 35 to 67 years (average, 54.2 years). The procedure and clinical results were evaluated from various viewpoints. RESULTS The duration of the operation ranged from 200 to 400 minutes (mean+/-standard deviation; 287.5+/-66.0 minutes) and blood loss from 10 to 1,500 mL (average, 515.5+/-507.9 mL). The weight of the spleen ranged from 500 to 850 g (average 608.0+/-126.6 g). Conversion to minimal open operation with a gasless lifting method was done in 1 patient because of uncontrolled bleeding from the splenic vein. There were no other major complications either intraoperatively or postoperatively. All patients had hypersplenism; preoperative platelet counts ranged from 1.6 to 6.8 x 10(4)/microL (average, 4.5+/-2.7 x 10(4) microL) and the postoperative count was from 5.9 to 36.0 x 10(4)/microL (average, 21.7+/-11.5 x 10(4) microL). Postoperative endoscopy revealed that varices disappeared, and no patient had recurrence of the varices after operation during the mean followup period of 12.8+/-4.1 months (average, 8 to 20 months). CONCLUSIONS The combination of laparoscopic gastric devascularization and splenectomy for sclerotherapy-resistant esophagogastric varices is considered a feasible and relatively safe surgical method for patients with hypersplenism.

[1]  B. Katzen,et al.  Percutaneous transjugular portosystemic shunt. , 1991, JAMA.

[2]  M. Hashizume,et al.  Angioarchitectural classification of esophageal varices and paraesophageal veins in selective left gastric venography. , 1989, Archives of surgery.

[3]  M. Hashizume,et al.  Recurrence rate of oesophageal varices with endoscopic banding ligation followed by injection sclerotherapy , 1994, The Lancet.

[4]  Hassab Ma Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. , 1967 .

[5]  M. Hashizume,et al.  Sclerotherapy-resistant esophageal varices with enormously enlarged cephalad collateral vessels predictable using portography. , 1995, Hepato-gastroenterology.

[6]  A. Gimson,et al.  Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices , 1993, The Lancet.

[7]  M. Hashizume,et al.  Editorial: Sclerotherapy resistant oesophageal varices: What are their clinical significance in prophylactic sclerotherapy? , 1996, Journal of gastroenterology and hepatology.

[8]  N. Mcintyre,et al.  Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy , 1992, Hepatology.

[9]  S. Sherlock Transjugular intrahepatic portal–systemic shunt , 1996, Journal of internal medicine.

[10]  N. Soehendra,et al.  Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. , 1986, Endoscopy.

[11]  H. Inoue,et al.  Minimal increase in serum interleukin-6 levels during laparoscopic cholecystectomy. , 1994, American journal of surgery.

[12]  M. Hashizume,et al.  Laparoscopic splenectomy with an ultrasonic dissector. , 1992, The New England journal of medicine.

[13]  Roger M. Williams,et al.  Controlled clinical trial of injection sclerotherapy for active variceal bleeding , 1989, Hepatology.

[14]  M. Talamini,et al.  Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. , 1994, The New England journal of medicine.

[15]  D. Trunkey,et al.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. , 1987, The New England journal of medicine.

[16]  M. Kutner,et al.  Distal Splenorenal Shunt Versus Endoscopic Sclerotherapy for Long‐term Management of Variceal Bleeding: Preliminary Report of a Prospective, Randomized Trial , 1986, Annals of surgery.

[17]  K. Inokuchi Present status of surgical treatment of esophageal varices in Japan: A nationwide survey of 3,588 patients , 1985, World journal of surgery.

[18]  J. Terblanche The surgeon's role in the management of portal hypertension. , 1989, Annals of surgery.

[19]  J. Amaral Laparoscopic cholecystectomy in 200 consecutive patients using an ultrasonically activated scalpel. , 1995, Surgical laparoscopy & endoscopy.

[20]  S. Lowenstein,et al.  Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophagal varices , 1992 .

[21]  K. Tanikawa,et al.  Distinctive portal venographic pattern in patients with sclerotherapy resistant oesophageal varices , 1996, Journal of gastroenterology and hepatology.

[22]  H. Conn,et al.  Transjugular Intrahepatic Portal‐systemic Shunts: The State of the Art , 1993 .

[23]  M. Endo,et al.  Hassab operation with intraoperative endoscopic injection sclerotherapy ("Hassab-EIS") for esophagogastric varices: with an autopsied case after excessive gastric vascular damage. , 1996, Hepato-gastroenterology.

[24]  M. Hashizume,et al.  Giant bar-type esophageal varices not eradicated by repeated injection sclerotherapy. , 1991, Gastrointestinal endoscopy.

[25]  M. Hashizume,et al.  Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: A nine‐year prospective study , 1992, Hepatology.

[26]  A. Gangl,et al.  Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. , 1989, Gut.